Baxter gets FDA EUA for Regiocit to support CRRT during Covid-19
Regiocit is a citrate-based replacement solution designed for use in continuous renal replacement therapy (CRRT) during Covid-19 pandemic
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Aug 20
Regiocit is a citrate-based replacement solution designed for use in continuous renal replacement therapy (CRRT) during Covid-19 pandemic
In a real-world user analysis, more than four in five participants using Flow Neuroscience's medication-free depression treatment reported…
14 Aug 20
Swoop is a point-of-care MR imaging device that can be directly placed at the patient’s bedside and controlled…
14 Aug 20
The new testing cartridge has been designed to avoid operator errors through its simplified procedure, and provide consistent…
14 Aug 20
To be tested, the user will simply obtain a drop of blood with a safety lancet and apply…
14 Aug 20
The volume of shares tendered into the offer within the acceptance period did not satisfy the minimum acceptance…
14 Aug 20
DRCG found an effective, low-cost method for the rapid diagnosis of both early marker and late marker, IgM/IgG…
14 Aug 20
The ViruShield Defender and The ViruShield Guardian, both crafted to improve comfort and increase a higher protective seal…
14 Aug 20
Working in as few as 3 minutes, Rapid LVO uses a vessel tracker in conjunction with assessment of…
14 Aug 20
Rapidly deployable solution offers "hands-free" continuous monitoring of patient vital signs in hospitals, senior facilities, or remotely at…